Cure MSA

Country specific patient information


Principal investigator:
Håkan Widner, MD, PhD

Professor of Neurology
Lund University Hospital
22185 Lund, Sweden

Expertise of the participating organization:

The group has since 15 years pioneered the field of cell transplantation in Parkinson's disease, and has been involved in clinical assessment of patients with this disease and other movement disorders. The group has also worked for many years with animal models of movement disorders and the development of new restorative and neuroprotective strategies.

Recent publications relevant to the EMSA-SG:


Kaufman E, Hall S, Surova Y, Widner H, Hansson O, Lindqvist D. Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy. PLoS One 2013;8:e62354.



Nilsson C, Markenroth Bloch K, Brockstedt S, Latt J, Widner H, Larsson EM. Tracking the neurodegeneration of parkinsonian disorders--a pilot study. Neuroradiology 2007; 49: 111-9. 


Widner H. Strategies to modify levodopa treatment. Adv Neurol 2003; 91: 229-36.


Lang AE, Widner H. Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Mov Disord 2002; 17 Suppl 3: S94-101.


Widner H. Neural tissue xenografting in neurodegenerative disorders: countdown to a clinical trial. Transplant Proc 2000; 32: 1174.


Widner H. Review of allo- and xenogeneic neural grafts in neurodegenerative disorders. Neural Tissue Transplantation Team(NETTLU). Transplant Proc 1999; 31: 936-8.


Widner H, Defer GL. Dyskinesias assessment: from CAPIT to CAPSIT. Core Assessment Program for Intracerebral Transplantations. Core Assessment Program for Surgical Interventional Therapies. Mov Disord 1999; 14 Suppl 1: 60-6.